Gnathostoma hispidum
Gnathostoma hispidum is a species of parasitic worm belonging to the Gnathostoma genus. It is known to infect various mammalian hosts, including humans, and is primarily found in Asia and Latin America.
Life Cycle[edit]
The life cycle of Gnathostoma hispidum involves several stages and multiple hosts. The adult worms reside in the stomach of the definitive host, where they lay eggs. These eggs are then excreted in the feces of the host. Once in the environment, the eggs hatch into first-stage larvae, which are ingested by small crustaceans, the first intermediate hosts. Within these hosts, the larvae develop into the second stage. These infected crustaceans are then eaten by a second intermediate host, typically a fish or amphibian, where the larvae further develop. The cycle is completed when a definitive host, such as a human, consumes the infected second intermediate host.
Clinical Manifestations[edit]
In humans, infection with Gnathostoma hispidum can lead to a condition known as gnathostomiasis. This disease is characterized by migratory swelling and pain, and can also cause serious complications such as neurological disorders and eye diseases if the larvae migrate to the central nervous system or the eyes.
Diagnosis and Treatment[edit]
Diagnosis of Gnathostoma hispidum infection is typically made through the identification of larvae in tissue samples, or through serological testing. Treatment usually involves the administration of anthelmintic drugs, such as ivermectin or albendazole.
Prevention[edit]
Prevention of Gnathostoma hispidum infection primarily involves avoiding the consumption of raw or undercooked fish or amphibians in areas where the parasite is endemic.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian